Before a foreign brand considers about notification, ingredient screening or artwork, there is a prior question that determines whether any of it applies: is the product a cosmetic at all?
For most products the answer is obvious. However, for a sizeable minority it is not, and those are the ones that cause issues. Whitening serums, anti-acne treatments, hair growth products, feminine washes, slimming creams and anything marketed on a physiological benefit all sit close to the line between cosmetics and medicines.
Getting this wrong is not a filing error. A product notified as a cosmetic that should have been registered as a medicine is being supplied unlawfully, and the exposure sits with the Cosmetic Notification Holder who submitted the notification.
NPRA publishes a decision process for exactly this question, in Annex I Part 8 of the Guidelines for Control of Cosmetic Products in Malaysia. This article sets out what you can and cannot claim, and covers the wording that most often takes an imported product outside the cosmetic category.
Why Classification Comes First
Malaysia does not evaluate cosmetics before they reach the market. Notification is a declaration, not an approval, which means nobody at NPRA checks your classification before your product goes on sale.The check happens afterwards. NPRA's post-market surveillance programme screens notified products, and the screening criteria explicitly include the product name and its claimed benefits alongside the formulation. A product found to be claiming beyond the cosmetic scope may have its notification cancelled and be subject to recall.
The Five-Step Decision Process
NPRA's guideline sets out five questions. A product must pass all five to be a cosmetic. Failing any one of them means it is not.| Step | Question | Fails if |
| 1. Composition | Does it contain only ingredients permitted under the ASEAN Cosmetic Directive, and none that are banned? | The formula contains a prohibited substance, or a restricted one used outside its conditions |
| 2. Target site | Is it intended for the external parts of the body - skin, hair, nails, lips, external genital organs - or the teeth and the mucous membranes of the mouth? | It is ingested, injected, or applied to the nasal mucous membranes or internal genitalia |
| 3. Main function | Is it intended exclusively or mainly to clean, perfume, change appearance, correct body odour, or protect and maintain those parts in good condition? | The primary purpose is therapeutic rather than cosmetic |
| 4. Presentation | Is it presented as treating or preventing disease? | Claims, labelling, packaging, promotional material, advertising, product form, or marketing targeting present it as a treatment |
| 5. Physiological function | Does it permanently restore, correct or modify a physiological function through pharmacological, immunological or metabolic action? | The mechanism is pharmacological rather than cosmetic |
Two of these deserve unpacking, because they are where foreign brands usually come unstuck.
Step 2 is about where the product goes, not what it does. Anything ingested or injected is ruled out, regardless of how it is marketed. The same applies to products for the nasal mucous membranes or internal genitalia. Oral care products are generally considered as cosmetics, because the teeth and the mucous membranes of the oral cavity are specifically included.
Step 5 turns on permanence and mechanism. The guideline notes that cosmetic products typically have effects that are not permanent and must be used regularly to maintain them. A claim that a product permanently changes how the body functions is a claim outside cosmetic scope. This is why “reduces the appearance of wrinkles” is a cosmetic claim and “reverses the ageing process” is not.
Step 4 covers more than your label. The guideline lists claims and their context, labelling and packaging including graphics, promotional literature and third-party testimonials, advertisements, the product form itself, and who the marketing targets. A compliant label attached to a website making therapeutic claims does not resolve the question.
The Secondary Function Allowance
This is the part most summaries miss, and it matters commercially.A cosmetic may have a secondary, minor function outside the main cosmetic scope. The guideline gives examples of acceptable secondary claim areas, and the list is broader than brands expect: dandruff, cellulite, bust contouring, anti-bacterial, dental caries, hair loss, acne and mouthwash.
So an anti-acne product is not automatically a medicine, and neither is an anti-dandruff shampoo or an anti-hair-fall treatment. What determines the outcome is whether the therapeutic element is secondary and minor, and how it is worded.
That is the distinction the claims guidance exists to draw. “Prevent, control or reduce acne” is acceptable. “Heals, treats or stops acne” is not. The underlying product may be identical but the classification differs because the claim differs.
What You Can and Cannot Claim
NPRA publishes worked examples by product category. The following covers the categories most relevant to imported products; the full list is in Annex I Part 8.Hair and scalp
Acceptable claims focus on control and appearance: controlling or reducing dandruff, anti-hair-fall where the cause is of physical nature such as breakage, increasing hair volume where the effect is physical and temporary, promoting healthy hair, strengthening or nourishing the hair root.Unacceptable claims assert biological outcomes: permanently eliminating dandruff, arresting or reversing hair loss, restoring hair cells, addressing hereditary or hormonal hair loss such as baldness or alopecia, stimulating hair growth, preventing grey hair, or treating cradle cap or seborrheic dermatitis.
The line here is between managing appearance and altering biology.
Skin
This is the largest category and the one with the most rejections.Acceptable: slowing or delaying the signs of ageing; preventing, controlling or reducing acne and breakouts; softening hard skin, corns, calluses and cracked heels; reducing dark spots, acne marks, wrinkles, pigmentation and stretch marks; improving the appearance of cellulite or scars; body shaping, contouring and firming.
Unacceptable: any reference to collagen or elastin production, inhibition of melanin synthesis, DNA repair or skin metabolism; references to blood or micro-circulation; nourishing, rejuvenating or regenerating cells; stimulating skin renewal or cell turnover; preventing, reversing or delaying the ageing process; healing or treating acne; treating warts; treating skin conditions such as pigmentation, hyperpigmentation, freckles, melasma, fragile capillaries or rosacea; preventing or treating cellulite; removing or eliminating scars; references to draining excess body fluid, swelling or oedema; slimming, fat loss, fat burning, inch loss or body metabolism; treating compromised skin such as bruises, wounds or burns; numbing the skin; and any reference to skin diseases including eczema, psoriasis, atopic dermatitis, vitiligo, varicose veins, rash, prickly heat or nappy rash.
Two patterns are worth extracting from that list. Mechanism claims fail. Naming a biological pathway such as melanin synthesis, collagen production, or cell turnover moves the claim out of cosmetic scope even where the visible benefit would have been acceptable. And “appearance of” is the key word. Reducing the appearance of a scar is acceptable; removing a scar is not.
This is the single most common reason Korean, Japanese and European skincare copy fails in Malaysia. The mechanism-led language that sells in those markets is precisely what is not permitted here.
Oral hygiene
Acceptable: whitening or bleaching teeth, preventing gum problems, maintaining healthy gums, relief of sensitive teeth, anti-cavity and anti-plaque, freshening breath, moisturizing.Unacceptable: treating or preventing any named oral disease or infection - abscess, gingivitis, gum boils, inflammation, mouth ulcers, periodontitis, periodontal disease, stomatitis, thrush; whitening tetracycline-induced stains; gum bleeding; any reference to pain or ache; effects on nerves; increasing or stimulating saliva production. Marketing a product for use as a gargle is also unacceptable.
Sunscreen
Acceptable: water or sweat resistant, preventing sunburn, UV filter, protecting the skin against UVA and UVB, preventing sun rays from damaging the skin. Where the SPF exceeds 50, it must be expressed as SPF 50+.Unacceptable: “sunblock”, “sweatproof” or “waterproof”, “UV block” or “UV cut”, any reference to skin cancer or reducing cancer occurrence, and any numerical SPF above 50 such as SPF 130.
The SPF point catches imported products constantly, because SPF values above 50 are printed openly in Japan and Korea.
Deodorants, fragrances and essential oils
Deodorants may claim to prevent or eliminate body odour and to reduce sweating, but not to completely prevent or stop perspiration.Fragrances may not claim aphrodisiac effect, sexual attraction or hormonal attraction.
Essential oil and aromatherapy products may claim calming, relaxing, refreshing, uplifting, moisturising and soothing effects. They may not reference diseases or illnesses such as insomnia, anxiety, colds, flu, migraine, cough, respiratory problems, menopause, period pain, PMS or the immune system, and may not claim effects on mental wellbeing such as improved focus, memory enhancement or relief of stress or sleeping disorders. Nor may they be presented as something to be taken or consumed - they must be applied to the skin.
Feminine and male hygiene
Acceptable: deodorising, removing or reducing odour, cleansing.Unacceptable: any reference to sexual pleasure such as tightening vaginal muscles, references to virility or sex drive, references to preserving normal flora, references to infection or inflammation, or reducing vaginal discharge.
The Cross-Category Rules
Four further rules apply regardless of product type, and each catches imported products regularly.“Cosmeceutical” is not permitted. Neither are references to mesotherapy, injection, microneedling or derma-roller use. This is a genuine problem for brands whose entire international positioning rests on the cosmeceutical label.
“Medicated” is not permitted, nor is “approved by the Ministry of Health”, nor “100% protection”.
GMP claims are not permitted. The use of a symbol, logo or statement relating to GMP certification or standards, including ISO 22716, is unacceptable on a cosmetic. Other certifications not related to GMP, such as ECOCERT, may be acceptable but must be substantiated. Manufacturers routinely assume that GMP certification is a selling point to display; in Malaysia it is not something you may put on the pack.
Safety claims cannot imply the absence of side effects. “No side effects”, “no harmful effects”, “no toxic or adverse effects” are all unacceptable. Products containing natural ingredients must not mislead consumers into assuming safety follows from being natural.
Quantitative claims are acceptable if substantiated. Figures such as 99.9%, “in 3 days” or “10x” are permitted where relevant evidence supports them. The evidence has to exist before the claim is made, since claim substantiation forms part of the Product Information File.
There are also prohibitions on religious references, on supernatural or superstitious elements, on imagery contrary to prevailing standards of decency, and on graphics referring to internal organs or substances of human origin such as growth factors, capillaries, lymph, hormones or nerves.
Where Imported Products Usually Fail
Mechanism-led marketing copy. The language that differentiates a product internationally - melanin inhibition, collagen stimulation, cell renewal - is the language that fails here.Whitening positioned as treatment. Reducing the appearance of dark spots and pigmentation is acceptable. Treating hyperpigmentation or melasma is not.
SPF values above 50 printed on the pack. These must be rendered as 50+.
“Cosmeceutical” in the brand architecture. If the term appears in the product name rather than only in marketing, this is a naming problem, not just a claims problem.
Anti-acne products assumed to be medicines. Some brands over-correct and assume any acne product requires medicine registration. Acne is a permitted secondary claim area; the wording determines the outcome.
Compliant label, non-compliant website. Presentation includes promotional literature, third-party testimonials and advertising. The classification is assessed on the whole presentation.
Ingested or injected formats. No claim wording rescues a product that fails Step 2. Oral supplements and injectables are outside cosmetic scope by definition.
GMP logos on packaging. Common on manufacturer-supplied artwork and not permitted in Malaysia.
What to Do Before You Commit
Run the five steps in order, and run them before artwork, before manufacturing for the Malaysian market, and before you appoint anyone.Start with composition and target site, because these are absolute and no rewording fixes them. Then examine the intended main function honestly - not the version in the marketing brief, but what the product is actually for.
Next, audit the full presentation. Label, carton, insert, website, social media, retailer listings, influencer briefs and any translated copy. Malaysia assesses the whole presentation, so a compliant carton with non-compliant e-commerce copy does not resolve the question.
Then map each claim against the acceptable and unacceptable examples, and rewrite where needed. Most claims can be brought within scope by shifting from mechanism to appearance and from treatment to management. Where a claim cannot survive that rewrite, the question is whether the product is genuinely a cosmetic.
Finally, assemble the substantiation. Every claim you keep must be supportable, and that evidence belongs in the Product Information File.
If the answer is that the product is not a cosmetic, that is a finding rather than a failure. It means a different registration pathway, a different timeline and a different cost base - all of which are far better understood before launch than after a post-market screening.
Frequently Asked Questions
1. How does NPRA decide whether a product is a cosmetic?Through a five-step process set out in Annex I Part 8 of the Guidelines for Control of Cosmetic Products in Malaysia, covering composition, target site of application, intended main function, product presentation and physiological effect. A product must satisfy all five.
2. Can a cosmetic product treat acne?
Acne is listed as an acceptable secondary claim area, so an anti-acne cosmetic is possible. The wording determines the outcome: preventing, controlling or reducing acne is acceptable, while healing, treating or stopping acne is not.
3. Are whitening products cosmetics in Malaysia?
They can be. Reducing the appearance of dark spots and pigmentation is acceptable. Claims referencing inhibition of melanin synthesis, or the treatment of hyperpigmentation, melasma or freckles, are not.
4. Can I use the word “cosmeceutical”?
No. “Cosmeceutical” is listed as an unacceptable claim, along with references to mesotherapy, injection, microneedling and derma-roller use.
5. Can I display our GMP certification on the packaging?
No. Symbols, logos or statements relating to GMP certification or standards, including ISO 22716, are unacceptable on cosmetic products. Certifications unrelated to GMP may be acceptable if substantiated.
6. How do I label a sunscreen above SPF 50?
As SPF 50+. Specific numerical values above 50 are not permitted, and “sunblock”, “UV block” and “waterproof” are also unacceptable.
7. Does the assessment cover only my label?
No. Product presentation includes claims and their context, labelling and packaging graphics, promotional literature and third-party testimonials, advertisements, the product form, and the target of the marketing.
8. What happens if a notified product is found to be claiming beyond cosmetic scope?
NPRA's post-market surveillance screens product names and claimed benefits alongside formulation. Products claiming beyond cosmetic scope may have their notification cancelled and may be subject to recall.
9. Are numerical performance claims allowed?
Yes, where substantiated by relevant evidence. Claims such as 99.9% or “in 3 days” are acceptable if the supporting data exists, and that data forms part of the Product Information File.
10. Can I say our product has no side effects?
No. Claims implying that a product is free from side effects or adverse effects are unacceptable, and natural composition must not be presented as implying safety.
Conclusion
Classification is the first regulatory decision in a Malaysian cosmetic launch and the one with the widest consequences. It determines which framework applies, what you can print, and whether the notification you file is the right instrument at all.The framework NPRA publishes is more accommodating than many brands assume. Acne, dandruff, hair loss and cellulite are all workable as secondary claim areas. What is not workable is the mechanism-led, treatment-framed language that differentiates products in other markets - the melanin pathways, the collagen stimulation, and the cell renewal.
For most imported products the practical question is therefore not whether the product can be sold in Malaysia as a cosmetic, but whether the marketing can be rewritten so that it may. That rewrite is considerably cheaper before artwork is printed than after a post-market screening.
Unsure whether your product is a cosmetic in Malaysia?
We assess borderline products against NPRA's classification criteria, review claims and marketing copy against the Guideline for Cosmetic Claims, and advise on the rewrites needed to bring a product within cosmetic scope where that is achievable.We also provide independent Cosmetic Notification Holder services, ingredient screening against the ASEAN Cosmetic Directive annexes, label and artwork review, NPRA notification through Quest 3+, and Product Information File compilation.
If your product sits close to the line, a classification review before launch is the cheapest hour you will spend on the Malaysian market. Contact us to discuss it.
